PTPN22 Human shRNA Plasmid Kit (Locus ID 26191)
CAT#: TR310061
PTPN22 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Product images
经常一起买 (2)
PTPN22 mouse monoclonal antibody,clone OTI6B1
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | PTPN22 Human shRNA Plasmid Kit (Locus ID 26191) |
Locus ID | 26191 |
UniProt ID | Q9Y2R2 |
Synonyms | LYP; LYP1; LYP2; PEP; PTPN8; PTPN22.5; PTPN22.6 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | PTPN22 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 26191). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_001193431, NM_001308297, NM_012411, NM_015967, NM_012411.1, NM_012411.2, NM_012411.3, NM_012411.4, NM_012411.5, NM_015967.1, NM_015967.2, NM_015967.3, NM_015967.4, NM_015967.5, NM_015967.6, NM_001193431.1, NM_001193431.2, BC017785, BC071670, NM_015967.7 |
Summary | This gene encodes of member of the non-receptor class 4 subfamily of the protein-tyrosine phosphatase family. The encoded protein is a lymphoid-specific intracellular phosphatase that associates with the molecular adapter protein CBL and may be involved in regulating CBL function in the T-cell receptor signaling pathway. Mutations in this gene may be associated with a range of autoimmune disorders including Type 1 Diabetes, rheumatoid arthritis, systemic lupus erythematosus and Graves' disease. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Mar 2009] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...